- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 49/16 - AntibodiesImmunoglobulinsFragments thereof
Patent holdings for IPC class A61K 49/16
Total number of patents in this class: 360
10-year publication summary
|
31
|
33
|
30
|
34
|
29
|
17
|
17
|
19
|
13
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astellas Pharma Inc. | 1030 |
10 |
| F. Hoffmann-La Roche AG | 7837 |
8 |
| Centre National de La Recherche Scientifique | 10886 |
7 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11020 |
7 |
| Institut Pasteur | 787 |
7 |
| OBI Pharma, Inc. | 128 |
7 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2973 |
6 |
| Purdue Research Foundation | 3856 |
5 |
| Annexon, Inc. | 81 |
5 |
| Georgia State University Research Foundation, Inc. | 353 |
5 |
| Universite de Caen Normandie | 125 |
5 |
| Centre hospitalier universitaire de Caen Normandie | 10 |
5 |
| The Trustees of the University of Pennsylvania | 4406 |
4 |
| University of Southern California | 2123 |
4 |
| Biogen International Neuroscience GmbH | 25 |
4 |
| Janssen Biotech, Inc. | 1714 |
4 |
| On Target Laboratories, LLC | 33 |
4 |
| University of Tennessee Research Foundation | 755 |
4 |
| Bioverativ USA Inc. | 43 |
4 |
| Abdera Therapeutics Inc. | 25 |
4 |
| Other owners | 251 |